NCT05242250View on ClinicalTrials.gov

Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial Fibrillation (DYNAMIC AF Registry)

TerminatedOBSERVATIONAL
Enrollment

392

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Atrial Fibrillation
Interventions
DEVICE

Catheter Ablation

Ablation RF technologies manufactured by Abbott.

Trial Locations (4)

19104

Penn Presbyterian Hospital, Philadelphia

21401

Luminis Health Anne Arundel Medical Center, Annapolis

35243

Grandview Medical Center, Birmingham

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Heart Rhythm Clinical and Research Solutions, LLC

OTHER